v3.20.1
Condensed Consolidated Statements of Shareholders Equity (Unaudited) - USD ($)
Common Stock
Capital in Excess of Par Value
Accumulated Deficit
Total
Beginning balance at Apr. 30, 2018 $ 731,694,210      
Beginning balance (in shares) at Apr. 30, 2018 731,694 1,434,328 (3,650,013) (1,483,991)
Net income (loss)     $ (7,207) $ (7,207)
Q1 stock-based compensation $ 3,937,501      
Q1 stock-based compensation (in shares) 3,938 2,757   6,695
Q1 stock issued for purchase $ 200,000      
Q1 stock issued for purchase (in shares) 200 500   700
Ending Balance at Jul. 31, 2018 $ 735,831,711      
Ending Balance (in shares) at Jul. 31, 2018 735,832 1,437,585 (3,657,220) (1,483,803)
Beginning balance at Apr. 30, 2018 $ 731,694,210      
Beginning balance (in shares) at Apr. 30, 2018 731,694 1,434,328 (3,650,013) (1,483,991)
Net income (loss)       $ (15,171)
Ending Balance at Jan. 31, 2019 $ 749,706,712      
Ending Balance (in shares) at Jan. 31, 2019 749,707 1,444,293 (3,665,184) (1,471,184)
Beginning balance at Jul. 31, 2018 $ 735,831,711      
Beginning balance (in shares) at Jul. 31, 2018 735,832 1,437,585 (3,657,220) (1,483,803)
Net income (loss)     $ (20,355) $ (20,355)
Q2 stock-based compensation $ 8,262,501      
Q2 stock-based compensation (in shares 8,262 3,946   12,208
Q2 sale of common stock $ 2,800,000      
Q2 sale of common stock (in shares) 2,800 2,200   5,000
Ending Balance at Oct. 31, 2018 $ 746,894,212      
Ending Balance (in shares) at Oct. 31, 2018 746,894 1,443,731 (3,677,575) (1,486,950)
Net income (loss)     $ 12,391 $ 12,391
Q3 stock-based compensation $ 2,812,500      
Q3 stock-based compensation (in shares) 2,813 562   3,375
Ending Balance at Jan. 31, 2019 $ 749,706,712      
Ending Balance (in shares) at Jan. 31, 2019 749,707 1,444,293 (3,665,184) (1,471,184)
Net income (loss)     $ 598,051 $ 598,051
Q4 stock-based compensation $ 2,812,500      
Q4 stock-based compensation (in shares) 2,812 5,063   7,875
Ending Balance at Apr. 30, 2019 $ 752,519,212      
Ending Balance (in shares) at Apr. 30, 2019 752,519 1,449,356 (3,067,133) (865,258)
Net income (loss)     $ 24,475 $ 24,475
Q1 stock-based compensation $ 2,812,500      
Q1 stock-based compensation (in shares) 2,813 16,875   19,688
Ending Balance at Jul. 31, 2019 $ 755,331,712      
Ending Balance (in shares) at Jul. 31, 2019 755,332 1,466,231 (3,042,658) (821,095)
Beginning balance at Apr. 30, 2019 $ 752,519,212      
Beginning balance (in shares) at Apr. 30, 2019 752,519 1,449,356 (3,067,133) (865,258)
Net income (loss)       $ 1,162,100
Ending Balance at Jan. 31, 2020 $ 830,956,712      
Ending Balance (in shares) at Jan. 31, 2020 830,957 2,309,449 (1,905,033) 1,235,373
Beginning balance at Jul. 31, 2019 $ 755,331,712      
Beginning balance (in shares) at Jul. 31, 2019 755,332 1,466,231 (3,042,658) (821,095)
Net income (loss)     $ 542,451 $ 542,451
Q2 stock-based compensation $ 75,312,500      
Q2 stock-based compensation (in shares 75,312 842,031   917,343
Ending Balance at Oct. 31, 2019 $ 830,644,212      
Ending Balance (in shares) at Oct. 31, 2019 830,644 2,308,262 (2,500,207) 638,699
Net income (loss)     $ 595,174 $ 595,174
Q3 stock-based compensation $ 312,500      
Q3 stock-based compensation (in shares) 313 1,187   1,500
Ending Balance at Jan. 31, 2020 $ 830,956,712      
Ending Balance (in shares) at Jan. 31, 2020 830,957 2,309,449 (1,905,033) 1,235,373